Literature DB >> 20069288

Congenital extrahepatic portosystemic shunt associated with heterotaxy and polysplenia.

Beverley Newman1, Jeffrey A Feinstein, Ronald A Cohen, Brian Feingold, Jacqueline Kreutzer, Hitendra Patel, Fandics P Chan.   

Abstract

BACKGROUND: Heterotaxy with polysplenia is associated with many cardiovascular anomalies including the occasional occurrence of congenital extrahepatic portosystemic shunts (CEPS). Missing this anomaly can lead to inappropriate and ineffective therapy.
OBJECTIVE: To emphasize the importance and associated anatomy of CEPS in conjunction with heterotaxy with polysplenia.
MATERIALS AND METHODS: Review of three young children who presented with cyanosis and pulmonary hypertension without a cardiac etiology. They were known (1) or discovered (2) to have heterotaxy with polysplenia.
RESULTS: There was absence of the intrahepatic inferior vena cava (IVC) with azygos or hemiazygos continuation in all three cases. In spite of normal liver function, they were discovered to have large portosystemic shunts, splenorenal in location, along with diffuse peripheral pulmonary arterial dilatation suggestive of CEPS (Abernethy malformation) with hepatopulmonary or, more accurately, portopulmonary syndrome. All CEPS were ipsilateral to the spleens. Patency of the portal veins in these cases allowed for percutaneous shunt closure with resolution of cyanosis.
CONCLUSION: CEPS is associated with heterotaxy with polysplenia and can be symptomatic because of pulmonary arteriovenous (AV) shunting. Portal and hepatic vein patency are critical for determining feasibility of CEPS closure.

Entities:  

Mesh:

Year:  2010        PMID: 20069288     DOI: 10.1007/s00247-009-1508-y

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  20 in total

1.  Hepatopulmonary syndromes.

Authors:  M J Krowka
Journal:  Gut       Date:  2000-01       Impact factor: 23.059

2.  Endovascular treatment of congenital portal vein fistulas with the Amplatzer occlusion device.

Authors:  José Alonso; Sergio Sierre; José Lipsich; Horacio Questa; Horacio Faella; Silvia Moguillansky
Journal:  J Vasc Interv Radiol       Date:  2004-09       Impact factor: 3.464

3.  Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 31-2004. A four-year-old boy with hypoxemia.

Authors:  T Bernard Kinane; Sjirk J Westra
Journal:  N Engl J Med       Date:  2004-10-14       Impact factor: 91.245

4.  Occurrence of hepatopulmonary syndrome in Budd-Chiari syndrome and the role of venous decompression.

Authors:  Binay K De; Sambit Sen; Pranab K Biswas; Sanjay K Mandal; Debasish Das; Utpalendu Das; Supriya Guru; Kausik Bandyopadhyay
Journal:  Gastroenterology       Date:  2002-04       Impact factor: 22.682

5.  Hepatic venous blood and the development of pulmonary arteriovenous malformations in congenital heart disease.

Authors:  D Srivastava; T Preminger; J E Lock; V Mandell; J F Keane; J E Mayer; H Kozakewich; P J Spevak
Journal:  Circulation       Date:  1995-09-01       Impact factor: 29.690

6.  Hepatopulmonary syndrome. Clinical observations and lack of therapeutic response to somatostatin analogue.

Authors:  M J Krowka; E R Dickson; D A Cortese
Journal:  Chest       Date:  1993-08       Impact factor: 9.410

7.  Polysplenia with pulmonary arteriovenous malformations.

Authors:  J Papagiannis; R J Kanter; E L Effman; P C Pratt; R Marcille; I B Browning; B E Armstrong
Journal:  Pediatr Cardiol       Date:  1993-03       Impact factor: 1.655

Review 8.  Congenital extrahepatic portosystemic shunts.

Authors:  Conor P Murray; Shi-Joon Yoo; Paul S Babyn
Journal:  Pediatr Radiol       Date:  2003-07-23

9.  Abernethy malformation: one of the etiologies of hepatopulmonary syndrome.

Authors:  Alfonso E Alvarez; Antônio F Ribeiro; Gabriel Hessel; Jamal Baracat; José D Ribeiro
Journal:  Pediatr Pulmonol       Date:  2002-11

Review 10.  Portopulmonary hypertension and hepatopulmonary syndrome.

Authors:  Marius M Hoeper; Michael J Krowka; Christian P Strassburg
Journal:  Lancet       Date:  2004-05-01       Impact factor: 79.321

View more
  11 in total

1.  Cardiopulmonary manifestations of portovenous shunts from congenital absence of the portal vein: pulmonary hypertension and pulmonary vascular dilatation.

Authors:  Y M Law; C L Mack; R J Sokol; M Rice; L Parsley; D Ivy
Journal:  Pediatr Transplant       Date:  2010-06-20

2.  Pulmonary arteriovenous malformations in a patient with single ventricle and polysplenia syndrome.

Authors:  Shinichiro Sakaki; Taiyu Hayashi; Hiroshi Ono
Journal:  BMJ Case Rep       Date:  2019-07-02

3.  Congenital Portosystemic Shunts in Children: Associations, Complications, and Outcomes.

Authors:  Frank DiPaola; Andrew T Trout; Ashley E Walther; Anita Gupta; Rachel Sheridan; Kathleen M Campbell; Greg Tiao; Jorge A Bezerra; Kevin E Bove; Manish Patel; Jaimie D Nathan
Journal:  Dig Dis Sci       Date:  2019-09-23       Impact factor: 3.199

4.  A consensus approach to the classification of pediatric pulmonary hypertensive vascular disease: Report from the PVRI Pediatric Taskforce, Panama 2011.

Authors:  Maria Jesus Del Cerro; Steven Abman; Gabriel Diaz; Alexandra Heath Freudenthal; Franz Freudenthal; S Harikrishnan; Sheila G Haworth; Dunbar Ivy; Antonio A Lopes; J Usha Raj; Julio Sandoval; Kurt Stenmark; Ian Adatia
Journal:  Pulm Circ       Date:  2011       Impact factor: 3.017

Review 5.  Inherited liver shunts in dogs elucidate pathways regulating embryonic development and clinical disorders of the portal vein.

Authors:  Frank G van Steenbeek; Lindsay van den Bossche; Peter A J Leegwater; Jan Rothuizen
Journal:  Mamm Genome       Date:  2011-11-04       Impact factor: 2.957

Review 6.  Fetal Magnetic Resonance Imaging of Malformations Associated with Heterotaxy.

Authors:  Rohit Loomba; Parinda H Shah; Robert H Anderson
Journal:  Cureus       Date:  2015-05-21

Review 7.  Non-cardiac issues in patients with heterotaxy syndrome.

Authors:  Shyam S Kothari
Journal:  Ann Pediatr Cardiol       Date:  2014-09

8.  In Search of "Hepatic Factor": Lack of Evidence for ALK1 Ligands BMP9 and BMP10.

Authors:  Teresa L Capasso; Sara M Trucco; Morgan Hindes; Tristin Schwartze; Jamie L Bloch; Jacqueline Kreutzer; Stephen C Cook; Cynthia S Hinck; Davide Treggiari; Brian Feingold; Andrew P Hinck; Beth L Roman
Journal:  Am J Respir Crit Care Med       Date:  2021-01-15       Impact factor: 21.405

9.  Refractory hypoxemia caused by hepatopulmonary syndrome: a case report.

Authors:  Morgen L Govindan; Kevin W Kuo; Maryam Ghadimi Mahani; Thomas P Shanley
Journal:  J Med Case Rep       Date:  2014-12-10

Review 10.  Congenital portosystemic venous shunt.

Authors:  M Papamichail; M Pizanias; N Heaton
Journal:  Eur J Pediatr       Date:  2017-12-14       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.